Mohamadi Sarkar leads a team of scientists within regulatory affairs at Altria that provides strategic direction toward developing the science and evidence for regulatory submissions for noncombustible tobacco products for Altria’s tobacco operating companies.
Before being appointed to his current position, Sarkar served as the director of clinical research. In that role, he enabled responsible product development and tobacco harm reduction by generating evidence from clinical studies.
Before joining Altria, Sarkar held a variety of positions at West Virginia University (WVU), including associate professor of clinical pharmacology, associate professor of genetics and developmental biology and associate professor of the Tobacco Research Center at the WVU Cancer Institute. Sarkar continued to teach at Virginia Commonwealth University, where he still holds an affiliate appointment teaching clinical pharmacology. He is also a fellow of the Royal Society of Medicine.
During his academic career, Sarkar worked on research related to smoking and health funded by the National Cancer Institute. He has authored more than 100 scientific peer-reviewed publications and presentations at scientific meetings. Sarkar has also participated in multiple seminar presentations and authored a variety of scientific book chapters related to his areas of expertise.
